$12.67
1.93% today
Nasdaq, Aug 12, 10:01 pm CET
ISIN
US6901451079
Symbol
OM

Outset Medical Inc Stock price

$12.67
-6.14 32.64% 1M
+0.97 8.29% 6M
-3.98 23.90% YTD
-0.53 4.03% 1Y
-305.93 96.02% 3Y
-897.53 98.61% 5Y
-897.53 98.61% 10Y
-897.53 98.61% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.24 1.93%

Key metrics

Basic
Market capitalization
$220.6m
Enterprise Value
$125.7m
Net debt
positive
Cash
$189.0m
Shares outstanding
17.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.9 | 1.8
EV/Sales
1.1 | 1.0
EV/FCF
negative
P/B
1.3
Financial Health
Equity Ratio
9.7%
Return on Equity
-477.2%
ROCE
-34.8%
ROIC
-98.0%
Debt/Equity
0.6
Financials (TTM | estimate)
Revenue
$115.3m | $125.7m
EBITDA
$-87.3m | $-39.9m
EBIT
$-92.9m | $-50.9m
Net Income
$-113.8m | $-94.4m
Free Cash Flow
$-96.7m
Growth (TTM | estimate)
Revenue
-7.8% | 10.6%
EBITDA
44.5% | 61.1%
EBIT
43.1% | 53.0%
Net Income
32.6% | 26.3%
Free Cash Flow
28.6%
Margin (TTM | estimate)
Gross
35.9%
EBITDA
-75.7% | -31.7%
EBIT
-80.6%
Net
-98.7% | -75.1%
Free Cash Flow
-83.9%
More
EPS
$-16.2
FCF per Share
$-5.5
Short interest
12.5%
Employees
354
Rev per Employee
$320.0k
Show more

Is Outset Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Outset Medical Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Outset Medical Inc forecast:

10x Buy
77%
3x Hold
23%

Analyst Opinions

13 Analysts have issued a Outset Medical Inc forecast:

Buy
77%
Hold
23%

Financial data from Outset Medical Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
115 115
8% 8%
100%
- Direct Costs 74 74
22% 22%
64%
41 41
35% 35%
36%
- Selling and Administrative Expenses 103 103
25% 25%
89%
- Research and Development Expense 31 31
44% 44%
27%
-87 -87
45% 45%
-76%
- Depreciation and Amortization 5.56 5.56
6% 6%
5%
EBIT (Operating Income) EBIT -93 -93
43% 43%
-81%
Net Profit -114 -114
33% 33%
-99%

In millions USD.

Don't miss a Thing! We will send you all news about Outset Medical Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Outset Medical Inc Stock News

Neutral
Seeking Alpha
6 days ago
Outset Medical, Inc. (NASDAQ:OM ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants James S. Mazzola - Head of Investor Relations Leslie L.
Neutral
GlobeNewsWire
6 days ago
Company raises 2025 revenue guidance to a range of $122 million to $126 million Company raises 2025 revenue guidance to a range of $122 million to $126 million
Neutral
GlobeNewsWire
13 days ago
SAN JOSE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced Brittni McGill has been named to the newly created role of Chief Nursing Officer where she will apply her extensive nurse executive leadership experience to help inc...
More Outset Medical Inc News

Company Profile

Outset Medical, Inc. is a medical technology company, which provides dialysis solutions to patients and healthcare providers. Its product Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.

Head office United States
CEO Leslie Trigg
Employees 354
Founded 2003
Website outsetmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today